Waters Corporation

WAT · Healthcare · · USD

379.32 USD

+0.00 (0.58%)

● Updated 2026-07-10 17:08 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 75

Trend & RS 96

Momentum 60

Fundamental 78

Macro 71

Liquidity 36

Component	Score	Weight
Technical	75.0	20%
Trend & RS	95.6	30%
Momentum	60.0	15%
Fundamental	77.8	10%
Macro	71.2	20%
Liquidity	35.7	5%

Trade Setup

Entry	378.46
Stop Loss	356.46 (5.8%)
Target 1 (1:1)	400.46 (+5.8%)
Target 2 (2:1)	422.46 (+11.6%)

ATR(14)	11.00 (2.9%)
Risk per Share	22.00
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	41.6	-0.34
Momentum	60.0	+0.40
Quality	37.0	-0.52
Composite	46.2

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	48.4	22.0	+120% above
P/B Ratio	2.4	4.0	Below

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

244.36

Market Price

379.32

Upside

-35.6%

Margin of Safety	-55.2%
Stage 1 PV (5yr FCF)	4,731,402,235
Terminal Value PV	19,261,187,766
Total Enterprise Value	23,992,590,001

Assumptions

Base FCF	615,821,690
Growth Rate (5yr)	25.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

49.54%

Full Kelly

24.77%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 76/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

59.19

RSI(14)

6.0687

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+8.1% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (9d since high)
Sector Outperformance	+15.8% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	59.19	NEUTRAL
Macd	6.0687	BEARISH
Ma Cross	355.15 / 349.82	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.07x	LOW

Key Levels

Level	Price
52-Week High	414.15
Bollinger Upper	386.6
SMA(200)	349.82
SMA(50)	355.15
SMA(20)	368.04
Current Price	379.32
Bollinger Lower	349.48
52-Week Low	275.05
ATR(14)	11.0

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.83x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.87x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.91x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.58x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.07x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	373.98	Above Kijun
Kijun-sen (26)	368.38	Base line
Senkou A	371.18	Leading span A
Senkou B	336.24	Leading span B
Cloud	336.24 – 371.18	Bullish (Green)
Price vs Cloud	378.46	Above Cloud
Chikou Span	379.77	Bearish
Alignment Score	3/4	BULLISH